Cancer-Related & Integrative Support Testing
A deeper look at early cancer risk, circulating tumor cells, and individualized treatment insights — beyond standard diagnostics.
This advanced panel supports individuals navigating cancer by assessing tumor activity, treatment sensitivity, and recurrence risk. It’s designed to complement conventional cancer care with personalized insights that guide our integrative planning and long-term survivorship.
What Makes This Panel Different?
Detects circulating tumor cells (CTCs) even before they may appear on imaging (Onco-Declare)
Monitors active cancer or remission status with real-time cell tracking (Onco-Trace, OncoCount)
Identifies which natural and conventional therapies are most effective for your cancer type (Onconomics / Onconomics Plus)
Evaluates tumor aggressiveness, resistance patterns, and immune response
Supports individualized treatment planning aligned with your values and needs
Who This Test Is Helpful For:
Individuals with a family history of cancer or seeking early detection
Patients with an active cancer diagnosis who want to monitor progress
Those exploring integrative treatment approaches tailored to their biology
Anyone in remission wanting to track recurrence risk proactively
People with limited response to conventional therapies looking for deeper insight
How It Works
Blood is drawn in clinic and shipped to RGCC’s international lab in Greece.
Results typically return in 2–3 weeks
We review the results together in detail in a follow-up visit
We use this information to develop a personalized care plan to complement your existing medical treatment